Nisa Investment Advisors LLC Trims Stock Holdings in The Cooper Companies, Inc. $COO

Nisa Investment Advisors LLC reduced its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 0.2% during the 2nd quarter, Holdings Channel reports. The fund owned 107,258 shares of the medical device company’s stock after selling 173 shares during the period. Nisa Investment Advisors LLC’s holdings in Cooper Companies were worth $7,632,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Zions Bancorporation National Association UT purchased a new stake in shares of Cooper Companies in the first quarter valued at $33,000. GKV Capital Management Co. Inc. purchased a new stake in shares of Cooper Companies in the first quarter valued at $40,000. J.Safra Asset Management Corp lifted its position in shares of Cooper Companies by 204.8% in the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock valued at $36,000 after acquiring an additional 340 shares in the last quarter. Larson Financial Group LLC lifted its position in shares of Cooper Companies by 1,071.0% in the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company’s stock valued at $61,000 after acquiring an additional 664 shares in the last quarter. Finally, HM Payson & Co. lifted its position in shares of Cooper Companies by 147.4% in the first quarter. HM Payson & Co. now owns 893 shares of the medical device company’s stock valued at $75,000 after acquiring an additional 532 shares in the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Robert W. Baird reduced their price objective on Cooper Companies from $97.00 to $85.00 and set an “outperform” rating on the stock in a research report on Thursday, August 28th. Mizuho reduced their target price on Cooper Companies from $105.00 to $90.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 16th. Piper Sandler reduced their target price on Cooper Companies from $105.00 to $83.00 and set an “overweight” rating on the stock in a research report on Thursday, August 28th. BNP Paribas upgraded Cooper Companies from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 22nd. Finally, JPMorgan Chase & Co. reduced their target price on Cooper Companies from $76.00 to $66.00 and set a “neutral” rating on the stock in a research report on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $84.77.

Insiders Place Their Bets

In other news, Director Lawrence Erik Kurzius acquired 2,000 shares of the stock in a transaction on Monday, September 29th. The stock was bought at an average price of $68.39 per share, with a total value of $136,780.00. Following the completion of the transaction, the director directly owned 5,777 shares of the company’s stock, valued at $395,089.03. The trade was a 52.95% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Albert G. White III acquired 10,000 shares of the company’s stock in a transaction dated Friday, September 5th. The shares were purchased at an average price of $68.39 per share, for a total transaction of $683,900.00. Following the purchase, the chief executive officer directly owned 226,151 shares of the company’s stock, valued at approximately $15,466,466.89. This trade represents a 4.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have acquired 17,975 shares of company stock valued at $1,216,346. Company insiders own 1.98% of the company’s stock.

Cooper Companies Stock Performance

Shares of NASDAQ:COO opened at $72.85 on Tuesday. The business has a 50-day moving average of $69.66 and a two-hundred day moving average of $73.18. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $108.01. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The firm has a market capitalization of $14.48 billion, a PE ratio of 35.89, a P/E/G ratio of 1.93 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The firm had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the prior year, the firm earned $0.96 EPS. The firm’s quarterly revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies announced that its board has authorized a share buyback plan on Wednesday, September 17th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the medical device company to repurchase up to 15.4% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s management believes its shares are undervalued.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.